Brands in de­mand: Keytru­da, Dupix­ent and Ozem­pic lead 2023 new sales pre­dic­tions — Eval­u­ate re­port

What’s old is new again for 2023 when it comes to phar­ma drug brands added sales this year. Led by Mer­ck’s Keytru­da and Sanofi and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.